Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
$RSII ~ Breakout stair-stepping to .03+
http://stockcharts.com/h-sc/ui?s=RSII
.02s coming up next!
.0163 @ HOD! Let's Go! $RSII / $RBIO
$RSII / $RBIO ~ Bulls are in control. Ask slapping!!
Awesome! Again, what is an MOASS for everyone to understand what we may be witnessing... $RSII / $RBIO
$RSII on verge of reversal! Chart looks sweet!! New highs look to be on our way. .05+ IMHO
-Name/ticker change $RSII --> $RBIO
-Distribution of scar cream end of this month or beginning of next month
http://stockcharts.com/h-sc/ui?s=RSII
$RSII ~ Ask getting pounded!! @HOD
We have momentum to run it high all month through to distribution news and name/ticker change news.
.05+ coming IMHO
$RSII / $RBIO
Agreed! This way it will be more calculated in measurement, rather than taking guesses on how much to take daily. As a true medicinal substance should be. Cannophen will help change the world and many peoples lives. Also, pills allow people to be more acceptable of marijuana because it conforms to today's standard form of medicine. Many people are not opposed to marijuana as medicine, but are opposed to smoking it or consuming it in other natures because of what the media has perceived it to be over the many many years.
$RSII / $RBIO
$RSII ~ Distribution late April/early May:
We are thrilled to announce that Rising Biosciences will also be rolling out its RBS0238 CLINICAL PEPTIDE SERUM (our scar serum) in Q2. “We could not be more excited to announce that after a recent meeting with the manufacturer of our clinical strength peptide serum, we are officially entering production phase for the product line and it will be on sale, available for national distribution, in late April/early May,” states Hall. “This means revenues, revenues and more revenues.”
https://www.otcmarkets.com/stock/RSII/news/Rising-Biosciences-Expedites-GrowthExpansion-with-In-House-Chemist-Laboratory-Analytical-Equipment-and-ProducerProcessor?id=186672
RSI @ 48 Still Oversold territory!
What's the bid @ on .014?
$RSII
$RSII ~ MMJ OBSERVER NEWS OUT:
Rising India Inc (OTCMKTS:RSII) Partners With PAO GROUP (OTCMKTS:PAOG)To Provide Cannophen™ To Patients In Ohio, Florida
By Melissa Kay / in Business / on Monday, 02 Apr 2018 08:01 AM / 0 Comment
Rising India Inc (OTCMRTS:RSII) announced recently that it’s partnering with PAO GROUP’s (OTCMKTS:PAOG) subsidiary, Alternative Medicine Centers of America to offer a free distribution of Cannophen™ to patients who want to stop smoking/vaping residing in Ohio, Florida. The two firms are launching a trial at all its medical clinics within Ohio and the patients will be served on a first-come-first-served basis.
The drug contains portions of THC, CBD and other specified strains of Terpenes for easier digestion and is designed as an alternative for patients who don’t want to use off-tasting tinctures and prefer fast reaction. In addition, the drug contains various beneficial elements for healing a wide range of medical conditions including treating symptoms of Parkinson and other rare conditions.
Furthermore, Cannophen™ can be used to cure people suffering from cancer particularly in alleviating the side effects of chemotherapy. Previous studies have shown that cannabinoids components found in medical cannabis help in slowing down the growth of cancerous cells in the body by blocking the creation of blood vessels that nourish tumor. Furthermore, other studies conducted on animals indicate that cannabinoids kill cancer cells while at the same time protecting the normal body cells from getting infected.
Other benefits include managing chronic pain, nausea, and other complex medical conditions. The program will commence after a week and the company has already obtained a license to distribute Cannophen™ and other RSII products in Ohio. The firm also plans to expand its services to other states once the trial is successfully implemented. Patients with chronic diseases will largely benefit from the program since they would not be required to pay for their medicines or treatment.
Meanwhile, Rising Biosciences has announced that it’s also planning to launch its RBS0238 CLINICAL PEPTIDE SERUM in the second quarter of the year. The firm will commence the production phase for Peptide Serum and it will be available in the market from April 2018. The company has also presented updates on the expansion strategy and it’s partnering with two other California producers to manufacture MMJ products.
https://www.mmjobserver.com/rising-india-inc-otcmktsrsii-partners-with-pao-group-otcmktspaogto-provide-cannophen-to-patients-in-ohio-florida/29359/
$RSII ~ MMJ OBSERVER NEWS OUT:
Rising India Inc (OTCMKTS:RSII) Partners With PAO GROUP (OTCMKTS:PAOG)To Provide Cannophen™ To Patients In Ohio, Florida
By Melissa Kay / in Business / on Monday, 02 Apr 2018 08:01 AM / 0 Comment
Rising India Inc (OTCMRTS:RSII) announced recently that it’s partnering with PAO GROUP’s (OTCMKTS:PAOG) subsidiary, Alternative Medicine Centers of America to offer a free distribution of Cannophen™ to patients who want to stop smoking/vaping residing in Ohio, Florida. The two firms are launching a trial at all its medical clinics within Ohio and the patients will be served on a first-come-first-served basis.
The drug contains portions of THC, CBD and other specified strains of Terpenes for easier digestion and is designed as an alternative for patients who don’t want to use off-tasting tinctures and prefer fast reaction. In addition, the drug contains various beneficial elements for healing a wide range of medical conditions including treating symptoms of Parkinson and other rare conditions.
Furthermore, Cannophen™ can be used to cure people suffering from cancer particularly in alleviating the side effects of chemotherapy. Previous studies have shown that cannabinoids components found in medical cannabis help in slowing down the growth of cancerous cells in the body by blocking the creation of blood vessels that nourish tumor. Furthermore, other studies conducted on animals indicate that cannabinoids kill cancer cells while at the same time protecting the normal body cells from getting infected.
Other benefits include managing chronic pain, nausea, and other complex medical conditions. The program will commence after a week and the company has already obtained a license to distribute Cannophen™ and other RSII products in Ohio. The firm also plans to expand its services to other states once the trial is successfully implemented. Patients with chronic diseases will largely benefit from the program since they would not be required to pay for their medicines or treatment.
Meanwhile, Rising Biosciences has announced that it’s also planning to launch its RBS0238 CLINICAL PEPTIDE SERUM in the second quarter of the year. The firm will commence the production phase for Peptide Serum and it will be available in the market from April 2018. The company has also presented updates on the expansion strategy and it’s partnering with two other California producers to manufacture MMJ products.
https://www.mmjobserver.com/rising-india-inc-otcmktsrsii-partners-with-pao-group-otcmktspaogto-provide-cannophen-to-patients-in-ohio-florida/29359/
We ($RSII / $PAOG) are the front runners in the pro-medical marijuana / anti-opioids movement!
Imagine if we get national recognition one of these days... which I can very much see it happening. Everyday there are new articles about people moving off of opioids and onto MMJ.
When that happens... DOLLAR-LAND!
WOW! Excellent find, Checkfan!!! Here we go folks... these prices won't be here for long IMHO
$RSII / $RBIO
.05+
TWITTER/FINRA WATCH: We are due for a tweet and ticker/name change any moment now! $RSII
https://twitter.com/RisingIndiaUSA?lang=en
http://otce.finra.org/DLSymbolNameChanges
$RSII ~ sellers dried up. Reversal on chart!
http://stockcharts.com/h-sc/ui?s=RSII
$RSII ~ sellers dried up. Reversal on chart!
Great things happening here! :) $RSII / $RBIO
.05+
Luckily $RSII management has always kept their word for shareholders. I believe they will continue to do so. They understand there is a lot of money for all of us to make here.
$RSII / $RBIO
And next month will be real revenues too! $RSII
I'm hoping these days are behind us and we can move forward through .02+
Congratulations!
Green days next week. Congrats to whoever got cheapies today! $RSII / $RBIO
What a beast $RSII is! Bulls took control of the second half today! WOW
$RSII to $RBIO (watch FINRA) Name change any moment!
.05+
Reversal in full effect! OVERSOLD! Market closed tomorrow! Huge week ahead of us. Buy em' up!!! $RSII
.05+
Ask is getting pounded! $RSII
$RSII @ HOD! Reversal in full effect!
haha! $RSII back to green! Let's Go!!! $$$$$$
If only other investors/traders can learn from you! Congratulations! GO $RSII / $RBIO
$RSII to $RBIO real soon...
$RSII ~ RSI (14) @46 - OVERSOLD!
Hoping it stays above the 50 MA for now. Then we can reverse back up as the chart has been doing the past few surges we've had. Hoping we get some great news on ticker change, or on Cannophen this week. That would be ideal! But overall, I truly believe this is going to be a huge year for $RSII, and we haven't seen nothin yet!
$RSII
RSI(14) @ 46 - OVERSOLD
$RSII selling dried up and way oversold. Looking for a nice bounce to take us back into the direction we intended to go.
.05+
$RSII ~ TWITTER: https://twitter.com/RisingIndiaUSA
I agree! Only a loss if you sell. I know what I own and understand that we are way undervalued here.
.05+
$RSII / $RBIO
That was quite profound! Thanks, x100xPercent. You just gained a follow mark!
$RSII
.05+
Cheers!
$RSII NEWS: We are thrilled to announce that Rising Biosciences will also be rolling out its RBS0238 CLINICAL PEPTIDE SERUM (our scar serum) in Q2. “We could not be more excited to announce that after a recent meeting with the manufacturer of our clinical strength peptide serum, we are officially entering production phase for the product line and it will be on sale, available for national distribution, in late April/early May,” states Hall. “This means revenues, revenues and more revenues.”
$RSII ~ NEWS: We are thrilled to announce that Rising Biosciences will also be rolling out its RBS0238 CLINICAL PEPTIDE SERUM (our scar serum) in Q2. “We could not be more excited to announce that after a recent meeting with the manufacturer of our clinical strength peptide serum, we are officially entering production phase for the product line and it will be on sale, available for national distribution, in late April/early May,” states Hall. “This means revenues, revenues and more revenues.”